Skip to content

Chinese Network of Pediatric Antiretroviral Therapy

Chinese Study of Pediatric Antiretroviral Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01210924
Acronym
CN-PART
Enrollment
400
Registered
2010-09-29
Start date
2010-04-30
Completion date
2015-12-31
Last updated
2018-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Immunodeficiency Syndrome

Keywords

children, Acquired Immunodeficiency Syndrome, antiretroviral therapy, China, Mortality

Brief summary

This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.

Interventions

None listed

Sponsors

National Center for AIDS/STD Control and Prevention, China CDC
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 15 Years
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of HIV infection * receiving triple antiretroviral drugs

Exclusion criteria

* clinical status not stable

Design outcomes

Primary

MeasureTime frame
The immunology and virologic outcomes2016

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026